1.Carbapenem-resistant Enterobacteriaceae: a growing threat. Nursing 2013, 43(7):65.
2.Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagace-Wiens PRS, Walkty A, Denisuik A, Golden A et al: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-beta-Lactamase Inhibitor Combinations. Drugs 2018, 78(1):65–98.
3.Solomon SL, Oliver KB: Antibiotic resistance threats in the United States: stepping back from the brink. American family physician 2014, 89(12):938–941.
4.Zhang R, Liu L, Zhou H, Chan EW, Li J, Fang Y, Li Y, Liao K, Chen S: Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China. EBioMedicine 2017, 19:98–106.
5.Rumbo C, Gato E, Lopez M, Ruiz de Alegria C, Fernandez-Cuenca F, Martinez-Martinez L, Vila J, Pachon J, Cisneros JM, Rodriguez-Bano J et al: Contribution of efflux pumps, porins, and beta-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrobial agents and chemotherapy 2013, 57(11):5247–5257.
6.Kim YA, Park YS: Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea. The Korean journal of internal medicine 2018, 33(2):247–255.
7.Martens E, Demain AL: The antibiotic resistance crisis, with a focus on the United States. The Journal of antibiotics 2017, 70(5):520–526.
8.Canton R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM et al: Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18(5):413–431.
9.McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann AC: Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PloS one 2017, 12(10):e0186195.
10.Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY: Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23(1):48 e49–48 e16.
11.Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A: Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive care medicine 2017, 43(10):1464–1475.
12.Durante-Mangoni E, Andini R, Zampino R: Management of carbapenem-resistant Enterobacteriaceae infections. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25(8):943–950.
13.Chinese XDRCWG, Guan X, He L, Hu B, Hu J, Huang X, Lai G, Li Y, Liu Y, Ni Y et al: Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22 Suppl 1:S15–25.
14.Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, Zhang CX, Ji P, Xie Y et al: Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22 Suppl 1:S9–14.
15.Friedman ND, Carmeli Y, Walton AL, Schwaber MJ: Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control. Infection control and hospital epidemiology 2017, 38(5):580–594.
16.. In: Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities. edn. Geneva; 2017.
17.Bar-Yoseph H, Hussein K, Braun E, Paul M: Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis. J Antimicrob Chemother 2016, 71(10):2729–2739.
18.Ramanathan YV, Venkatasubramanian R, Nambi PS, Ramabathiran M, Venkataraman R, Thirunarayan MA, Samundeeswari P, Ramakrishnan N: Carbapenem-resistant enterobacteriaceae screening: A core infection control measure for critical care unit in India? Indian journal of medical microbiology 2018, 36(4):572–576.
19.Kurtz SL: Introduction of New Theory for Hand Hygiene Surveillance: Healthcare Environment Theory. Res Theory Nurs Pract 2018, 32(2):144–167.
20.Martischang R, Buetti N, Balmelli C, Saam M, Widmer A, Harbarth S: Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions. Antimicrobial resistance and infection control 2019, 8:37.
21.Mathers AJ, Vegesana K, German Mesner I, Barry KE, Pannone A, Baumann J, Crook DW, Stoesser N, Kotay S, Carroll J et al: Intensive Care Unit Wastewater Interventions to Prevent Transmission of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Organisms. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2018, 67(2):171–178.
22.Suen LKP, Siu GKH, Guo YP, Yeung SKW, Lo KYK, O’Donoghue M: The public washroom - friend or foe? An observational study of washroom cleanliness combined with microbiological investigation of hand hygiene facilities. Antimicrobial resistance and infection control 2019, 8:47.
23.Wang J, Liu F, Tan JBX, Harbarth S, Pittet D, Zingg W: Implementation of infection prevention and control in acute care hospitals in Mainland China - a systematic review. Antimicrobial resistance and infection control 2019, 8:32.
24.Li M, Wang X, Wang J, Tan R, Sun J, Li L, Huang J, Wu J, Gu Q, Zhao Y et al: Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study. Antimicrobial resistance and infection control 2019, 8:8.
25.Poirel L, Walsh TR, Cuvillier V, Nordmann P: Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011, 70(1):119–123.
26.Cerceo E, Deitelzweig SB, Sherman BM, Amin AN: Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options. Microb Drug Resist 2016, 22(5):412–431.
27.Alvi N, Tipoo FA, Imran A, Ashraf MN, Qidwai A, Khursheed M, Moiz B, Adil SN, Fadoo Z, Altaf S et al: Burden of Cardiac Siderosis in a Thalassemia-Major Endemic Population: A Preliminary Report From Pakistan. J Pediatr Hematol Oncol 2016, 38(5):378–383.
28.Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D: Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 2011, 377(9761):228–241.
29.Kousouli E, Zarkotou O, Politi L, Polimeri K, Vrioni G, Themeli-Digalaki K, Tsakris A, Pournaras S: Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens. Eur J Clin Microbiol Infect Dis 2018, 37(1):43–50.
30.Cohen MJ, Block C, Levin PD, Schwartz C, Gross I, Weiss Y, Moses AE, Benenson S: Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective. Infection control and hospital epidemiology 2011, 32(7):673–678.
31.Pfrimmer DM, Johnson MR, Guthmiller ML, Lehman JL, Ernste VK, Rhudy LM: Surveillance: A Nursing Intervention for Improving Patient Safety in Critical Care Environment. Dimens Crit Care Nurs 2017, 36(1):45–52.
32.Skodvin B, Wathne JS, Lindemann PC, Harthug S, Nilsen RM, Charani E, Syre H, Kittang BR, Kleppe LKS, Smith I: Use of microbiology tests in the era of increasing AMR rates- a multicentre hospital cohort study. Antimicrobial resistance and infection control 2019, 8:28.
33.David S, Reuter S, Harris SR, Glasner C, Feltwell T, Argimon S, Abudahab K, Goater R, Giani T, Errico G et al: Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nature microbiology 2019.